The Role of Macrophages in the Pathogenesis of Atherosclerosis

Alexander V Blagov1, Alexander M Markin2, Anastasia I Bogatyreva2

  • 1Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia.

Cells
|February 25, 2023
PubMed

Insights

Macrophages play a critical role in atherosclerosis, with different types influencing disease progression or regression. Understanding these macrophage phenotypes offers potential therapeutic strategies for atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathogenesis of Atherosclerosis

Background:

  • Atherosclerosis involves diverse cell types, notably immune and endothelial cells.
  • Macrophages are key players, exhibiting varied roles in atherogenesis and inflammation.
  • Distinct macrophage phenotypes significantly impact the progression and regression of atherosclerotic lesions.

Purpose of the Study:

  • To review the multifaceted roles of macrophage phenotypes in atherosclerosis.
  • To examine the implications of macrophage-derived foam cells in disease progression.
  • To explore the influence of macrophage cytokine production on the inflammatory environment of atherosclerotic lesions.

Main Methods:

  • Review of existing literature on macrophage biology in atherosclerosis.
  • Analysis of studies detailing macrophage phenotype-specific functions.
  • Examination of therapeutic strategies targeting macrophage modulation.

Main Results:

  • Different macrophage populations exert opposing effects on atherosclerosis.
  • Macrophage foam cell formation is a critical event in lesion development.
  • Macrophage-derived cytokines dictate the pro-inflammatory or anti-inflammatory milieu.

Conclusions:

  • Targeting specific macrophage phenotypes presents a promising therapeutic avenue for atherosclerosis.
  • Modulating macrophage activity, including foam cell formation and cytokine profiles, is crucial for disease management.
  • Further research into macrophage-centric therapies could lead to novel drug development for cardiovascular diseases.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
54.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
29
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
20
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
14
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
42